The acting commissioner of the Food and Drug Administration and the director of the Centers for Disease Control and Prevention told a top White House official their agencies may not be able to approve a more expansive booster plan.
The agency’s accelerated approval of the medication was welcomed by some advocates and doctors as a step forward in treating the devastating disease but strongly criticized by many experts who say the medication hasn’t been shown to be effective.
The church camp outbreak fueled by the highly transmissible delta variant occurred at the Crossing Camp in Rushville, Ill., which did not urge teens to be vaccinated or masked.
Promoted by conservative talk show hosts, politicians and even some physicians as an effective treatment for covid-19, the medication has soared in popularity despite having no proven anti-viral benefits — and also some clear harms.
Butler County Judge J. Gregory Howard ordered West Chester Hospital to treat Jeffrey Smith, 51, with ivermectin for three weeks, as requested by his wife.
The agency is supposed to decide by Sept. 9 whether the embattled company — and many other e-cigarette manufacturers — will be allowed to keep selling their products and, if so, under what conditions.